Adderall vs Vyvanse: Differences for Adult ADHD

Adderall and Vyvanse both treat ADHD with amphetamine, but they deliver it differently. Adderall is a mix of amphetamine salts (dextroamphetamine and levoamphetamine in a 3:1 ratio), sold as immediate-release tablets and as Adderall XR capsules. Vyvanse (lisdexamfetamine) is an inactive prodrug that the body converts to dextroamphetamine, mainly in the blood by red blood cells.

In practice, the differences that matter to adults are how the dose feels across the day, how long it lasts, whether you also have binge eating disorder (only Vyvanse is FDA-approved for it), what your pharmacy can actually fill, and cost. The evidence does not show that one is better for adults in general. Both are Schedule II controlled substances with the same boxed warning, and the choice belongs in a conversation with your prescriber.

At a glance

How each one works in the body

Immediate-release Adderall reaches its peak blood level in about 3 hours, and its label describes a first dose on waking with one or two more doses spaced 4 to 6 hours apart. That schedule gives flexibility, since a prescriber can plan later doses around your day, at the cost of more peaks and dips.

Adderall XR packs two kinds of beads into one capsule, one released right away and one delayed, which stretches the release. According to its label, a single morning XR dose produced blood levels comparable to the same total amount of immediate-release Adderall taken in two doses 4 hours apart. Peak levels come about 7 hours after the dose, roughly 4 hours later than with the tablet.

Vyvanse works differently. The capsule contains lisdexamfetamine, which has to be split by enzymes in red blood cells before it becomes active dextroamphetamine; lisdexamfetamine itself is not metabolized by cytochrome P450 enzymes, although the label still warns that CYP2D6 inhibitors can raise exposure to the dextroamphetamine it releases. The label reports that blood levels of dextroamphetamine were equivalent whether lisdexamfetamine was taken as a solution or as intact capsules, and it allows the capsule to be opened and mixed into a drink. How the onset feels varies from person to person.

How long each lasts

Duration is the most common practical question, and it is where people differ most. The FDA labels describe what was measured in trials, not a guaranteed number of hours for everyone.

• Vyvanse in adults: in a workplace-style study of 142 adults, attention scores were better than placebo at every time point measured, from 2 to 14 hours after the dose.
• Vyvanse in children: in a classroom study of children 6 to 12, the effect was significant from 2 to 12 hours after the dose but not at 1 hour.
• Adderall XR: the label's mean elimination half-life for dextroamphetamine in adults is 10 hours, and for levoamphetamine 13 hours. Half-life describes how fast the drug leaves the blood, which is not the same as how long you feel it working.

Longer is not always better. A dose that is still active late in the evening can disrupt sleep, and insomnia is among the most common side effects on both labels. NICE's adult ADHD guidance even suggests considering dexamfetamine (an off-label use in the UK) for adults who respond to lisdexamfetamine but cannot tolerate its longer effect profile. Food changes timing a little: a high-fat meal delays Vyvanse's peak by about 1 hour and Adderall XR's by about 2.5 hours, without changing the total amount absorbed. If your medication fades too early or lasts too late, see when ADHD medication stops working before assuming the drug has failed.

What the evidence says about effectiveness in adults

There is no strong evidence that one of these two drugs works better than the other for adults as a group. A large network meta-analysis of ADHD medications, published in Lancet Psychiatry in 2018, included 133 double-blind randomized trials. In adults, amphetamines showed a larger effect than placebo on clinician-rated symptoms than methylphenidate did, and the authors concluded that amphetamines are a preferred first choice for short-term treatment of adults. The same analysis found amphetamines less well tolerated than placebo in adults, measured by people stopping because of side effects.

That analysis grouped all amphetamines, including lisdexamfetamine, into a single category, so it does not settle Adderall versus Vyvanse. It also lacked enough data to judge effects at 26 and 52 weeks. NICE lists lisdexamfetamine or methylphenidate as first-line options for adults, with a switch considered after a 6-week trial at an adequate dose that has not helped enough. For the broader question of which stimulant family to start with, see methylphenidate vs amphetamine.

Side effects and safety screening

Because both deliver amphetamine, their side-effect lists overlap. In adults, the labels' most common adverse reactions include:

Before either drug, the labels direct prescribers to:

• Ask about heart disease, including a family history of sudden death or ventricular arrhythmia, and do a physical exam.
• Avoid use in people with known structural heart abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease or other serious heart disease.
• Monitor blood pressure and pulse during treatment.
• Screen for risk factors for a manic episode, such as a history of depressive symptoms or a family history of suicide, bipolar disorder or depression.
• Assess the risk of misuse before prescribing and keep reassessing it.

What heart monitoring looks like in practice is covered in ADHD medication and your heart. The Vyvanse label also notes that breastfeeding is not recommended and that a pregnancy exposure registry exists for ADHD medications; anyone pregnant or planning pregnancy should read psychiatric medications during pregnancy and talk with the prescriber.

Binge eating disorder: the one clear point of difference

Vyvanse is the only one of the two with an FDA-approved indication for moderate to severe binge eating disorder in adults. For someone with both ADHD and binge eating disorder, that can make it a sensible first choice to discuss. The label is explicit that Vyvanse is not indicated or recommended for weight loss, and that the safety and effectiveness of Vyvanse for treating obesity have not been established. Adderall has no binge eating indication. Treatment options beyond medication are covered in binge eating disorder treatment options.

Day-to-day practicalities

Small label details shape daily life more than pharmacology does. Both Vyvanse and Adderall XR are taken once daily in the morning, and the Vyvanse label specifically advises avoiding afternoon doses because of the potential for insomnia. Neither label allows splitting a single capsule into smaller doses; you take the whole capsule, or its whole contents mixed as directed. Immediate-release Adderall is different, since it is taken in more than one dose through the day.

Some combinations are off limits. Both labels list use with a monoamine oxidase inhibitor (MAOI), or within 14 days of stopping one, as contraindicated because of the risk of a hypertensive crisis; that includes the antibiotic linezolid and intravenous methylene blue. Both labels also set lower dose limits for people with severe kidney impairment, so tell your prescriber about kidney disease.

Keep a simple record for the first weeks: what time you took the dose, when you noticed it working, when it faded, how you slept and what you ate. That record makes the follow-up visit far more useful than a general impression, especially when the question is whether to adjust the timing, the dose or the product.

If your prescriber suggests switching between them

Switching from one amphetamine product to another is common, usually because of duration, side effects, cost or supply. NICE suggests judging a stimulant after a 6-week trial at an adequate dose before deciding it has not helped enough. Within the Adderall family, the XR label states that people on divided doses of immediate-release Adderall may be switched to the same total daily dose of XR taken once daily. Moving between Adderall and Vyvanse is not that simple: the Vyvanse label gives no milligram-for-milligram conversion from Adderall, so the prescriber sets a new starting dose and adjusts it.

Expect a few weeks of adjustment, with follow-up on sleep, appetite, mood, blood pressure and pulse. NICE's adult pathway moves between lisdexamfetamine and methylphenidate when a 6-week trial of one has not helped enough. The reasoning behind choosing a class is laid out in methylphenidate vs amphetamine.

Supply, generics and cost

Availability can decide the question. When checked on 26 October 2026, the FDA drug shortage database listed immediate-release mixed amphetamine salts tablets as a current shortage, first posted in October 2022, and lisdexamfetamine capsules and chewable tablets as a current shortage, first posted in July 2023. Availability varies by manufacturer and strength, so one pharmacy may have a strength another lacks. Practical steps are in what to do if your pharmacy is out.

Generic lisdexamfetamine became available after FDA approved several first generics of Vyvanse capsules and chewable tablets in August 2023. FDA states that approved generics work the same way and carry the same benefits and risks as the brand. Insurance plans often prefer one product, which affects out-of-pocket cost more than list price; see prior authorization for psychiatric medications and lowering prescription costs.

Prescription rules that apply to both

Amphetamine and lisdexamfetamine are both listed in Schedule II of the federal Controlled Substances Act regulations. That status brings tighter prescribing and pharmacy rules than most medications. For telehealth, federal DEA flexibilities that allow controlled medications to be prescribed by telemedicine without a prior in-person visit have been extended through 31 December 2026. State rules can be stricter, and what happens after that date is not yet settled, so ask your prescriber how it applies to you. The state-by-state questions are covered in telehealth psychiatry from another state.

Which one might suit you: questions for your prescriber

These are the factors that usually tip the decision. None of them is a rule, and a prescriber may weigh them differently for good reasons.

Do not switch between Adderall and Vyvanse, change the dose, or use someone else's supply on your own. The products are not dosed milligram for milligram, and a switch should be planned by the prescriber. A thoughtful start often begins at a low dose; the practice's article on low-dose ADHD medication explains that approach.

How Dr. Lewis's team approaches ADHD medication

The practice offers an ADHD assessment for adults and children, in person or by telehealth, and its treatment plans may include lifestyle changes, nutrition and supplements, psychotherapy, executive-function coaching, and medications when appropriate. Ongoing medication management is part of the practice's care. Questions about care options, scheduling and insurance can be raised on a free discovery call. Details are on the ADHD assessment page, and the full set of decision guides is in the choosing psychiatric care guide.

Frequently asked questions

Is Vyvanse stronger than Adderall?

Not in a simple sense. They deliver amphetamine in different ways and are dosed differently, so milligrams cannot be compared directly. Which feels stronger depends on the person and the dose, and only your prescriber can compare doses for you.

Does Vyvanse have less abuse potential because it is a prodrug?

Vyvanse still carries the same FDA boxed warning for abuse, misuse and addiction as Adderall, and it is still Schedule II. Store it securely and never share it.

Can I take Adderall XR and immediate-release Adderall on the same day?

Some prescribers add a short-acting dose to a long-acting one, but that is an individual decision. Do not combine them unless your prescriber has set that plan.

Is generic Vyvanse the same as the brand?

FDA approved several first generics of Vyvanse in August 2023 and states that approved generics work the same way as the brand. Supply of both has been affected by shortages. See generic vs brand-name psychiatric medications.

Will either medication help me lose weight?

Neither is approved for weight loss, and the Vyvanse label says it is not indicated or recommended for that use. Appetite loss is a side effect, not a treatment goal.

What if neither works well for me?

Some people who do not do well on an amphetamine do better on methylphenidate, and non-stimulants are another route. See adult ADHD treatment options compared.

Sources

1. Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
2. Adderall XR (mixed salts of a single-entity amphetamine product) extended-release capsules prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
3. Adderall (mixed amphetamine salts) tablets prescribing information. Teva Pharmaceuticals / DailyMed (NLM), 2024. dailymed.nlm.nih.gov
4. 21 CFR 1308.12 Schedule II. Electronic Code of Federal Regulations (DEA), 2026. ecfr.gov
5. FDA Drug Shortages Database: amphetamine mixed salts tablets; lisdexamfetamine dimesylate capsules and chewable tablets. U.S. Food and Drug Administration, 2026. dps.fda.gov
6. FDA approves multiple generics of ADHD and BED treatment. U.S. Food and Drug Administration, 2023. fda.gov
7. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727-738 (Cortese S et al.), PubMed 30097390, 2018. pubmed.ncbi.nlm.nih.gov
8. Attention deficit hyperactivity disorder: diagnosis and management (NG87), Recommendations. National Institute for Health and Care Excellence, 2019. nice.org.uk
9. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Drug Enforcement Administration and HHS, Federal Register, 2025. federalregister.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.